Statin use and risk of cerebral aneurysm rupture: a hospital-based case–control study in Japan

Y Yoshimura, Y Murakami, M Saitoh, T Yokoi… - Journal of Stroke and …, 2014 - Elsevier
Background Recent reports have showed that some statins have protective effects in
experimental cerebral aneurysm models. We conducted a case–control study to investigate …

The murine angiotensin II-induced abdominal aortic aneurysm model: rupture risk and inflammatory progression patterns

RY Cao, T Amand, MD Ford, U Piomelli… - Frontiers in …, 2010 - frontiersin.org
An abdominal aortic aneurysm (AAA) is an enlargement of the greatest artery in the body
defined as an increase in diameter of 1.5-fold. AAAs are common in the elderly population …

Opportunities in abdominal aortic aneurysm research: epidemiology, genetics, and pathophysiology

H Kuivaniemi, JR Elmore - Annals of vascular surgery, 2012 - Elsevier
Aortic aneurysms are a complex genetic disorder with known environmental risk factors such
as smoking. Along the length of the aorta, significant heterogeneity occurs in the distribution …

Abdominal aortic aneurysms and diabetes mellitus

K Pafili, I Gouni-Berthold, N Papanas… - Journal of Diabetes and …, 2015 - Elsevier
There is accumulating evidence that risk profiles differ between coronary artery disease and
abdominal aortic aneurysms (AAAs). However, diabetes mellitus (DM) appears to be …

Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation

CP Hans, SN Koenig, N Huang, J Cheng… - … , and vascular biology, 2012 - Am Heart Assoc
Objective—Activation of inflammatory pathways plays a critical role in the development of
abdominal aortic aneurysms (AAA). Notch1 signaling is a significant regulator of the …

Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm

LS Ang, WA Boivin, SJ Williams, H Zhao… - Cell death & …, 2011 - nature.com
Granzyme B (GZMB) is a proapoptotic serine protease that is released by cytotoxic
lymphocytes. However, GZMB can also be produced by other cell types and is capable of …

Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms

Y Iida, B Xu, GM Schultz, V Chow, JJ White… - PloS one, 2012 - journals.plos.org
Background Despite the importance of the renin-angiotensin (Ang) system in abdominal
aortic aneurysm (AAA) pathogenesis, strategies targeting this system to prevent clinical …

Inhibition of Receptor-Interacting Protein Kinase 1 with Necrostatin–1s ameliorates disease progression in elastase-induced mouse abdominal aortic aneurysm model

Q Wang, T Zhou, Z Liu, J Ren, N Phan, K Gupta… - Scientific reports, 2017 - nature.com
Abdominal aortic aneurysm (AAA) is a common aortic disease with a progressive nature.
There is no approved pharmacological treatment to effectively slow aneurysm growth or …

Abdominal aortic aneurysms: an autoimmune disease?

VP Jagadesham, DJA Scott, SR Carding - Trends in molecular medicine, 2008 - cell.com
Abdominal aortic aneurysms (AAAs) are a multifactorial degenerative vascular disorder. One
of the defining features of the pathophysiology of aneurysmal disease is inflammation …

[HTML][HTML] A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion

H Takagi, M Matsui, T Umemoto - Journal of vascular surgery, 2010 - Elsevier
BACKGROUND: Despite the absence of a relationship between cholesterol and abdominal
aortic aneurysm (AAA) expansion, there is evidence from a number of studies to suggest that …